Nasal spray for dry eye disease and tear film stability
Treatments studied
Part of Eyes & vision, Injuries & trauma clinical trials.
This study tests whether a nasal spray can improve dry eye symptoms and tear production in people with mild to moderate meibomian gland dysfunction (a common cause of dry eye). You'll use the spray daily while the research team monitors your eye health and comfort over several weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older with the ability to consent to participate
- Moderate dry eye symptoms (OSDI score above 13) and mild to moderate meibomian gland dysfunction (blocked oil glands in the eyelids)
- Vision of 20/40 or better with glasses or contacts
- Willing to stop all prescription dry eye medications and eye drops during the study, but continue warm compresses or eyelid cleaning if you use them
- No active eye infections, severe eyelid inflammation, or recent eye surgery (within 3–12 months depending on surgery type)
- No chronic sinus problems, nosebleeds, or bleeding disorders
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a nasal spray (varenicline) to see if it can relieve discomfort and dryness from contact lens wear. If you wear daily disposable soft contacts and experience end-of-day eye dryness, you may be eligible.
This trial tests a food supplement designed to improve dry eye symptoms by targeting the microbiome. It may help if you have dry eye due to meibomian gland problems and are not using contact lenses or certain other eye treatments.
This trial tests a new VR device called Lacrima VR to see if it helps people with dry eye disease and meibomian gland dysfunction (a common cause of dry eye). It might be helpful if your dry eye symptoms have lasted at least 3 months and are moderate to severe.
This study tests a new eye drop (5% VVN001) to treat dry eye disease that hasn't improved enough with artificial tears. It may help people with moderate-to-severe dry eye and low tear production.
This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.
This study tests whether a special eyelid massage technique using a support plate can help unblock and improve meibomian glands—small glands in your eyelids that produce tear oil. If your glands are blocked or not working well, it may be causing your dry eyes, and this treatment might help.
Hear when a new Dry Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.